Health Care & Life Sciences » Pharmaceuticals | Catalyst Pharmaceutical Partners Inc.

Catalyst Pharmaceutical Partners Inc. | Ownership

Companies that own Catalyst Pharmaceutical Partners Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Broadfin Capital LLC
6,772,764
6.6%
-40,000
3.14%
06/30/2018
Consonance Capital Management LP
6,044,719
5.89%
1,050,000
1.09%
06/30/2018
BlackRock Fund Advisors
5,541,085
5.4%
1,215,153
0%
06/30/2018
venBio Select Advisor LLC
4,497,042
4.38%
-195,301
0.52%
06/30/2018
The Vanguard Group, Inc.
4,084,141
3.98%
268,200
0%
06/30/2018
Baker Bros. Advisors LP
3,621,962
3.53%
-759,110
0.08%
06/30/2018
Armistice Capital LLC
1,700,000
1.66%
1,700,000
0.44%
06/30/2018
Mangrove Partners
1,677,944
1.64%
169,635
0.87%
06/30/2018
Millennium Management LLC
1,610,176
1.57%
227,918
0.01%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
1,535,432
1.5%
741,480
0%
06/30/2018

About Catalyst Pharmaceutical Partners

View Profile
Address
355 Alhambra Circle
Coral Gables Florida 33134
United States
Employees -
Website http://www.catalystpharma.com
Updated 07/08/2019
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.